Literature DB >> 9506593

Thrombolysis-related intracranial hemorrhage: a radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.

J M Gebel1, C A Sila, M A Sloan, C B Granger, K W Mahaffey, J Weisenberger, C L Green, H D White, J M Gore, W D Weaver, R M Califf, E J Topol.   

Abstract

BACKGROUND AND
PURPOSE: Intracranial hemorrhage (ICH) is a serious complication of thrombolytic therapy. We systematically reviewed the radiographic features of 244 cases of symptomatic ICH complicating thrombolysis for acute myocardial infarction in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-1) trial, correlated these observations with clinical data, and speculated on hemorrhage pathogenesis.
METHODS: CT scans from 244 patients suffering symptomatic ICH were systematically reviewed for selected radiographic features, including ICH type, location, hematoma characteristics, mass effect features, hydrocephalus, and preexisting lesions. Hematoma volume was estimated by computer-assisted volumetric analysis. Data from this analysis were correlated with clinical data including hypertension, anticoagulation, age, thrombolytic regimen, and ICH timing.
RESULTS: Most hemorrhages were large (median [25th, 75th percentile] volume, 72 mL [39, 118]), solitary (66%), lobar (77%), confluent (80%), and intraparenchymal (82%) with a blood/fluid level (82%) and little edema (median [25th, 75th percentile] volume, 9 mL [5, 16]). Hydrocephalus (P<.001), any one mass effect feature (P<.001), intraventricular hemorrhage (P=.022), mottled hematoma appearance (P=.050), and hematoma blood/fluid level (P<.001) were associated with higher hemorrhage volume in the radiographic analysis, as were older age (P=.005), treatment with combined streptokinase and tissue plasminogen activator (P=.034), and hemorrhage onset 8 to 13 hours after treatment (P=.008) in the clinical analysis. Subdural hemorrhage was a high-volume subgroup whose risk increased with antecedent trauma (P=.026) or syncope (P=.006). Deep intraparenchymal hemorrhage was associated with hypertension (P=.016), and multifocal ICH occurred significantly earlier after treatment (P=.002).
CONCLUSIONS: Although the majority of postthrombolytic ICH are large, solitary, and supratentorial, the spectrum is diverse. Features of mass effect reflected the large volumes, and hematoma characteristics of mottling and blood/fluid levels were frequent. Thrombolysis-related coagulopathy and age appear to be the most important identifiable factors in the genesis of postthrombolytic ICH, but the hemorrhage subtype seen may reflect an interaction with other factors such as hypertension, ICH timing, antecedent head trauma, and syncope.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9506593     DOI: 10.1161/01.str.29.3.563

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  19 in total

1.  Thrombolysis in patients with a brain tumour.

Authors:  R Rubinshtein; R Jaffe; M Y Flugelman; B Karkabi; B S Lewis
Journal:  Heart       Date:  2004-12       Impact factor: 5.994

2.  Challenges and controversies in the medical management of primary and antithrombotic-related intracerebral hemorrhage.

Authors:  Michael Moussouttas
Journal:  Ther Adv Neurol Disord       Date:  2012-01       Impact factor: 6.570

3.  Frameless stereotactic aspiration and thrombolysis of spontaneous intracerebral hemorrhage.

Authors:  Ryan J Barrett; Rahat Hussain; William M Coplin; Samera Berry; Penelope M Keyl; Daniel F Hanley; Robert R Johnson; J Ricardo Carhuapoma
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

Review 4.  Thrombolytic therapy for stroke: a review with particular reference to elderly patients.

Authors:  K W Muir; M Roberts
Journal:  Drugs Aging       Date:  2000-01       Impact factor: 3.923

Review 5.  Intracerebral hemorrhage: pathophysiology and therapy.

Authors:  Guohua Xi; Matthew E Fewel; Ya Hua; B Gregory Thompson; Julian T Hoff; Richard F Keep
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

Review 6.  [Recent studies concerning treatment of acute, ischemic infarcts].

Authors:  I Q Grunwald; T Struffert; U Dorenbeck; P Papanagiotou; W Reith
Journal:  Radiologe       Date:  2005-05       Impact factor: 0.635

7.  Brain microhemorrhages detected on T2*-weighted gradient-echo MR images.

Authors:  Yoshito Tsushima; Jun Aoki; Keigo Endo
Journal:  AJNR Am J Neuroradiol       Date:  2003-01       Impact factor: 3.825

8.  Long-term outcomes of post-thrombolytic intracerebral hemorrhage in ischemic stroke patients.

Authors:  Kiersten E Norby; Farhan Siddiq; Malik M Adil; Saqib A Chaudhry; Adnan I Qureshi
Journal:  Neurocrit Care       Date:  2013-04       Impact factor: 3.210

Review 9.  Role of thrombin in CNS damage associated with intracerebral haemorrhage: opportunity for pharmacological intervention?

Authors:  Hideki Matsuoka; Rikuzo Hamada
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

10.  Early edema in warfarin-related intracerebral hemorrhage.

Authors:  Joshua M Levine; Ryan Snider; David Finkelstein; Mahmut E Gurol; Rishi Chanderraj; Eric E Smith; Steven M Greenberg; Jonathan Rosand
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.